Test: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 49: | Line 49: | ||
|colspan="1" style = "font-size:80%;"|var | |colspan="1" style = "font-size:80%;"|var | ||
|colspan="1" style = "font-size:84%;"|Particularly on cells with plasma cell features | |colspan="1" style = "font-size:84%;"|Particularly on cells with plasma cell features | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |CD200 | |colspan="1" style = "font-size:90%; color:black;" |CD200 | ||
| Line 86: | Line 76: | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"|Expect expression | |colspan="1" style = "font-size:84%;"|Expect expression | ||
|- | |||
|colspan="1" style = "font-size:90%; color:black;" |CD23 | |||
|colspan="1" style = "background:#00b8e6;"| | |||
|colspan="1" style = "font-size:80%;"|- | |||
|colspan="1" style = "font-size:84%;"|Infrequent but reported | |||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |CD25 | |colspan="1" style = "font-size:90%; color:black;" |CD25 | ||
| Line 96: | Line 91: | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"|Generally not expressed by LPL | |colspan="1" style = "font-size:84%;"|Generally not expressed by LPL | ||
|- | |||
|colspan="1" style = "font-size:90%; color:black;" |CD79b | |||
|colspan="1" style = "background:#006699;"| | |||
|colspan="1" style = "font-size:80%;"|- | |||
|colspan="1" style = "font-size:84%;"|Generally expressed | |||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |CD103 | |colspan="1" style = "font-size:90%;" |CD103 | ||
Revision as of 10:53, 14 July 2023
Background to flow cytometric diagnosis
Cells of LPL share features of mature B-cell differentation and features of early plasma cell differentiation, and have mixed populations with features of each (although proportions vary). This can be a challenging diagnosis by flow cytometry alone, but other modalities can generally make this diagnosis clear.
| Immunophenotype of LPL | |||
|---|---|---|---|
| CD45 expression | |||
| Typically expression of CD45 is similar to that of normal T and B cells. | |||
| Major markers useful in CLL diagnosis | |||
| Marker | Freq | Level | Comment |
| CD19 | - | Generally CD19 will be expressed | |
| CD38 | - | ||
| κ/λ | Light chain retriction usually detected | ||
| CD5 | - | Uncommon but seen in some cases | |
| CD138 | var | Particularly on cells with plasma cell features | |
| CD200 | - | Detected infrequently | |
| FMC7 | Generally expressed | ||
| Other relevant markers | |||
| CD10 | - | Expression may be seen | |
| CD11C | - | ||
| CD20 | - | Expect expression | |
| CD23 | - | Infrequent but reported | |
| CD25 | - | ||
| CD43 | - | Generally not expressed by LPL | |
| CD79b | - | Generally expressed | |
| CD103 | - | ||
Key to table:
Key to colour code for expression frequency Click for link
Key to expression strength code and use Click for link